Wall Street The pharmaceutical giant's stock has reached a 13-figure capitalisation and now trades at one of the highest valuations in the entire pharmaceutical sector, at around 50 times expected earnings over the next 12 months Pharmaceutical giant Eli Lilly has reached $1 trillion in market capitalisation, becoming the first company in the industry to enter the small club of companies valued at 13 figures, hitherto dominated by technology giants such as Apple, Microsoft, Nvidia, Alphabet, Amazon, Meta, Tesla, Broadcom and Berkshire Hathaway
BPC-157 And Recovery from Musculoskeletal Injuries Research on animal models shows that BPC-157 has the potential to improve performance and recovery from injuries
Compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness, or quality before marketing
Lilly's complaint against Henry Meds alleges the telehealth company improperly referenced Lilly's approved drugs and clinical trials on its website in order to sell more compounded versions
it forms water-soluble chelate compounds with iron that are rapidly eliminated by the kidneys
Endometriosis peptides are showing clinical promise for managing chronic pelvic pain and inflammation that affects 10% of women of reproductive age worldwide